Esteemed Innovators to be Honored for California Life Sciences Contributions at 2016 Pantheon DiNA Award Program in San Francisco
Peter J. Pitts In medicine, it’s considered good practice to figure out what’s causing a patient’s illness before prescribing the cure. When it comes to pharmaceutical pricing, politicians and special interest groups should do the same. Recently, politicians along with the nonprofit Public Citizen have slammed pharmaceutical firms for “needlessly high” drug prices. Public Citizen, … Continue reading Opinion: Let’s not talk drug price, without value.
The adoption of Personalized Medicine is being driven by the omnipresence of Next-Generation Sequencing (NGS), the fast pace of technological innovations in the field, and the President’s Precision Medicine Initiative. To date, however, only a relatively small fraction of the patient population has had their DNA fully sequenced, while a larger segment has undergone limited … Continue reading Emerging Themes in Personalized Medicine
09/11/2015 Digital health is a growing field that promises improved patient education, wellness, engagement, access to care, and outcomes, among other things. However, with these new technologies come unique regulatory concerns that digital health companies must consider. While there are a wide range of digital health companies with different focuses, some common legal issues must … Continue reading Key Regulatory Considerations for Digital Health Companies